Clarus Delivers Good News With $500m Fund

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 048″]

OIS Co-Chair Emmett Cunningham explains how Clarus will invest new $500m fund in ophthalmology and beyond.

Podcast Guest


Emmett T. Cunningham Jr., MD, PhD, MPH

Dr. Cunningham joined Clarus Ventures with 20+ years in the biomedical and biopharmaceutical sectors. Prior, Dr. Cunningham was the SVP, Medical Strategy at Eyetech Pharmaceuticals. He helped build and lead the team that developed and commercialized Macugen.

View Full Profile